nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—Leukopenia—Mercaptopurine—Crohn's disease	0.00335	0.00335	CcSEcCtD
Sibutramine—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00335	0.00335	CcSEcCtD
Sibutramine—Migraine—Mesalazine—Crohn's disease	0.00332	0.00332	CcSEcCtD
Sibutramine—Affect lability—Mesalazine—Crohn's disease	0.00332	0.00332	CcSEcCtD
Sibutramine—Neuritis—Prednisone—Crohn's disease	0.0033	0.0033	CcSEcCtD
Sibutramine—Glaucoma—Prednisone—Crohn's disease	0.00327	0.00327	CcSEcCtD
Sibutramine—Face oedema—Mesalazine—Crohn's disease	0.00326	0.00326	CcSEcCtD
Sibutramine—Mood swings—Mesalazine—Crohn's disease	0.0032	0.0032	CcSEcCtD
Sibutramine—Arthralgia—Mercaptopurine—Crohn's disease	0.00319	0.00319	CcSEcCtD
Sibutramine—Blood creatinine increased—Mesalazine—Crohn's disease	0.00316	0.00316	CcSEcCtD
Sibutramine—Liver function test abnormal—Mesalazine—Crohn's disease	0.00312	0.00312	CcSEcCtD
Sibutramine—Abscess—Prednisone—Crohn's disease	0.00311	0.00311	CcSEcCtD
Sibutramine—Dry skin—Mesalazine—Crohn's disease	0.0031	0.0031	CcSEcCtD
Sibutramine—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00309	0.00309	CcSEcCtD
Sibutramine—Oedema—Mercaptopurine—Crohn's disease	0.00306	0.00306	CcSEcCtD
Sibutramine—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00304	0.00304	CcSEcCtD
Sibutramine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00299	0.00299	CcSEcCtD
Sibutramine—Petechiae—Prednisone—Crohn's disease	0.00299	0.00299	CcSEcCtD
Sibutramine—Gastritis—Mesalazine—Crohn's disease	0.00299	0.00299	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00298	0.00298	CcSEcCtD
Sibutramine—Skin disorder—Mercaptopurine—Crohn's disease	0.00297	0.00297	CcSEcCtD
Sibutramine—Abdominal distension—Mesalazine—Crohn's disease	0.00294	0.00294	CcSEcCtD
Sibutramine—Acne—Prednisone—Crohn's disease	0.00293	0.00293	CcSEcCtD
Sibutramine—Dysphagia—Mesalazine—Crohn's disease	0.00292	0.00292	CcSEcCtD
Sibutramine—Asthma—Mesalazine—Crohn's disease	0.00292	0.00292	CcSEcCtD
Sibutramine—Influenza—Mesalazine—Crohn's disease	0.00292	0.00292	CcSEcCtD
Sibutramine—Anorexia—Mercaptopurine—Crohn's disease	0.00292	0.00292	CcSEcCtD
Sibutramine—Eosinophilia—Mesalazine—Crohn's disease	0.00289	0.00289	CcSEcCtD
Sibutramine—Pneumonia—Azathioprine—Crohn's disease	0.00287	0.00287	CcSEcCtD
Sibutramine—Angina pectoris—Mesalazine—Crohn's disease	0.00284	0.00284	CcSEcCtD
Sibutramine—Contusion—Prednisone—Crohn's disease	0.00282	0.00282	CcSEcCtD
Sibutramine—Bronchitis—Mesalazine—Crohn's disease	0.00281	0.00281	CcSEcCtD
Sibutramine—Amenorrhoea—Prednisone—Crohn's disease	0.0028	0.0028	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00279	0.00279	CcSEcCtD
Sibutramine—Dysuria—Mesalazine—Crohn's disease	0.00273	0.00273	CcSEcCtD
Sibutramine—Arthropathy—Prednisone—Crohn's disease	0.00271	0.00271	CcSEcCtD
Sibutramine—Pollakiuria—Mesalazine—Crohn's disease	0.0027	0.0027	CcSEcCtD
Sibutramine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00266	0.00266	CcSEcCtD
Sibutramine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00266	0.00266	CcSEcCtD
Sibutramine—Weight increased—Mesalazine—Crohn's disease	0.00266	0.00266	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00264	0.00264	CcSEcCtD
Sibutramine—Leukocytosis—Prednisone—Crohn's disease	0.00262	0.00262	CcSEcCtD
Sibutramine—Pneumonia—Mesalazine—Crohn's disease	0.00262	0.00262	CcSEcCtD
Sibutramine—Hypercholesterolaemia—Prednisone—Crohn's disease	0.0026	0.0026	CcSEcCtD
Sibutramine—Depression—Mesalazine—Crohn's disease	0.0026	0.0026	CcSEcCtD
Sibutramine—Cataract—Prednisone—Crohn's disease	0.00259	0.00259	CcSEcCtD
Sibutramine—Haemoglobin—Azathioprine—Crohn's disease	0.00258	0.00258	CcSEcCtD
Sibutramine—Haemorrhage—Azathioprine—Crohn's disease	0.00257	0.00257	CcSEcCtD
Sibutramine—Renal failure—Mesalazine—Crohn's disease	0.00256	0.00256	CcSEcCtD
Sibutramine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00255	0.00255	CcSEcCtD
Sibutramine—Stomatitis—Mesalazine—Crohn's disease	0.00254	0.00254	CcSEcCtD
Sibutramine—Conjunctivitis—Mesalazine—Crohn's disease	0.00253	0.00253	CcSEcCtD
Sibutramine—Urinary tract infection—Mesalazine—Crohn's disease	0.00253	0.00253	CcSEcCtD
Sibutramine—Sweating—Mesalazine—Crohn's disease	0.0025	0.0025	CcSEcCtD
Sibutramine—Haematuria—Mesalazine—Crohn's disease	0.00248	0.00248	CcSEcCtD
Sibutramine—Epistaxis—Mesalazine—Crohn's disease	0.00246	0.00246	CcSEcCtD
Sibutramine—Sinusitis—Mesalazine—Crohn's disease	0.00244	0.00244	CcSEcCtD
Sibutramine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00242	0.00242	CcSEcCtD
Sibutramine—Haemoglobin—Mesalazine—Crohn's disease	0.00235	0.00235	CcSEcCtD
Sibutramine—Rhinitis—Mesalazine—Crohn's disease	0.00234	0.00234	CcSEcCtD
Sibutramine—Fluid retention—Prednisone—Crohn's disease	0.00234	0.00234	CcSEcCtD
Sibutramine—Haemorrhage—Mesalazine—Crohn's disease	0.00234	0.00234	CcSEcCtD
Sibutramine—Pharyngitis—Mesalazine—Crohn's disease	0.00232	0.00232	CcSEcCtD
Sibutramine—Immune system disorder—Azathioprine—Crohn's disease	0.00232	0.00232	CcSEcCtD
Sibutramine—Oedema peripheral—Mesalazine—Crohn's disease	0.0023	0.0023	CcSEcCtD
Sibutramine—Chills—Azathioprine—Crohn's disease	0.0023	0.0023	CcSEcCtD
Sibutramine—Arrhythmia—Azathioprine—Crohn's disease	0.00229	0.00229	CcSEcCtD
Sibutramine—Alopecia—Azathioprine—Crohn's disease	0.00227	0.00227	CcSEcCtD
Sibutramine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00225	0.00225	CcSEcCtD
Sibutramine—Oesophagitis—Prednisone—Crohn's disease	0.00225	0.00225	CcSEcCtD
Sibutramine—Ecchymosis—Prednisone—Crohn's disease	0.00223	0.00223	CcSEcCtD
Sibutramine—Eye disorder—Mesalazine—Crohn's disease	0.00218	0.00218	CcSEcCtD
Sibutramine—Tinnitus—Mesalazine—Crohn's disease	0.00218	0.00218	CcSEcCtD
Sibutramine—Hyperkinesia—Prednisone—Crohn's disease	0.00215	0.00215	CcSEcCtD
Sibutramine—Sepsis—Prednisone—Crohn's disease	0.00214	0.00214	CcSEcCtD
Sibutramine—Angiopathy—Mesalazine—Crohn's disease	0.00212	0.00212	CcSEcCtD
Sibutramine—Euphoric mood—Prednisone—Crohn's disease	0.00212	0.00212	CcSEcCtD
Sibutramine—Immune system disorder—Mesalazine—Crohn's disease	0.00211	0.00211	CcSEcCtD
Sibutramine—Chills—Mesalazine—Crohn's disease	0.0021	0.0021	CcSEcCtD
Sibutramine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00209	0.00209	CcSEcCtD
Sibutramine—Ill-defined disorder—Azathioprine—Crohn's disease	0.00207	0.00207	CcSEcCtD
Sibutramine—Alopecia—Mesalazine—Crohn's disease	0.00206	0.00206	CcSEcCtD
Sibutramine—Anaemia—Azathioprine—Crohn's disease	0.00206	0.00206	CcSEcCtD
Sibutramine—Diabetes mellitus—Prednisone—Crohn's disease	0.00205	0.00205	CcSEcCtD
Sibutramine—Malaise—Azathioprine—Crohn's disease	0.00201	0.00201	CcSEcCtD
Sibutramine—Flatulence—Mesalazine—Crohn's disease	0.002	0.002	CcSEcCtD
Sibutramine—Leukopenia—Azathioprine—Crohn's disease	0.002	0.002	CcSEcCtD
Sibutramine—Vascular purpura—Prednisone—Crohn's disease	0.002	0.002	CcSEcCtD
Sibutramine—Tension—Mesalazine—Crohn's disease	0.002	0.002	CcSEcCtD
Sibutramine—Dysgeusia—Mesalazine—Crohn's disease	0.00199	0.00199	CcSEcCtD
Sibutramine—Nervousness—Mesalazine—Crohn's disease	0.00198	0.00198	CcSEcCtD
Sibutramine—Cardiac failure congestive—Prednisone—Crohn's disease	0.00197	0.00197	CcSEcCtD
Sibutramine—Back pain—Mesalazine—Crohn's disease	0.00197	0.00197	CcSEcCtD
Sibutramine—Muscle spasms—Mesalazine—Crohn's disease	0.00196	0.00196	CcSEcCtD
Sibutramine—Vomiting—Mercaptopurine—Crohn's disease	0.00194	0.00194	CcSEcCtD
Sibutramine—Injury—Prednisone—Crohn's disease	0.00194	0.00194	CcSEcCtD
Sibutramine—Rash—Mercaptopurine—Crohn's disease	0.00193	0.00193	CcSEcCtD
Sibutramine—Dermatitis—Mercaptopurine—Crohn's disease	0.00193	0.00193	CcSEcCtD
Sibutramine—Vision blurred—Mesalazine—Crohn's disease	0.00192	0.00192	CcSEcCtD
Sibutramine—Tremor—Mesalazine—Crohn's disease	0.00191	0.00191	CcSEcCtD
Sibutramine—Amnesia—Prednisone—Crohn's disease	0.0019	0.0019	CcSEcCtD
Sibutramine—Increased appetite—Prednisone—Crohn's disease	0.0019	0.0019	CcSEcCtD
Sibutramine—Myalgia—Azathioprine—Crohn's disease	0.0019	0.0019	CcSEcCtD
Sibutramine—Arthralgia—Azathioprine—Crohn's disease	0.0019	0.0019	CcSEcCtD
Sibutramine—Ill-defined disorder—Mesalazine—Crohn's disease	0.00189	0.00189	CcSEcCtD
Sibutramine—Anaemia—Mesalazine—Crohn's disease	0.00188	0.00188	CcSEcCtD
Sibutramine—Discomfort—Azathioprine—Crohn's disease	0.00188	0.00188	CcSEcCtD
Sibutramine—Angioedema—Mesalazine—Crohn's disease	0.00186	0.00186	CcSEcCtD
Sibutramine—Purpura—Prednisone—Crohn's disease	0.00185	0.00185	CcSEcCtD
Sibutramine—Malaise—Mesalazine—Crohn's disease	0.00183	0.00183	CcSEcCtD
Sibutramine—Vertigo—Mesalazine—Crohn's disease	0.00183	0.00183	CcSEcCtD
Sibutramine—Syncope—Mesalazine—Crohn's disease	0.00182	0.00182	CcSEcCtD
Sibutramine—Leukopenia—Mesalazine—Crohn's disease	0.00182	0.00182	CcSEcCtD
Sibutramine—Nausea—Mercaptopurine—Crohn's disease	0.00182	0.00182	CcSEcCtD
Sibutramine—Infection—Azathioprine—Crohn's disease	0.00181	0.00181	CcSEcCtD
Sibutramine—Palpitations—Mesalazine—Crohn's disease	0.0018	0.0018	CcSEcCtD
Sibutramine—Loss of consciousness—Mesalazine—Crohn's disease	0.00179	0.00179	CcSEcCtD
Sibutramine—Osteoarthritis—Prednisone—Crohn's disease	0.00179	0.00179	CcSEcCtD
Sibutramine—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00179	0.00179	CcSEcCtD
Sibutramine—Thrombocytopenia—Azathioprine—Crohn's disease	0.00178	0.00178	CcSEcCtD
Sibutramine—Cough—Mesalazine—Crohn's disease	0.00178	0.00178	CcSEcCtD
Sibutramine—Skin disorder—Azathioprine—Crohn's disease	0.00177	0.00177	CcSEcCtD
Sibutramine—Affect lability—Prednisone—Crohn's disease	0.00176	0.00176	CcSEcCtD
Sibutramine—Hypertension—Mesalazine—Crohn's disease	0.00176	0.00176	CcSEcCtD
Sibutramine—Psychotic disorder—Prednisone—Crohn's disease	0.00175	0.00175	CcSEcCtD
Sibutramine—Myalgia—Mesalazine—Crohn's disease	0.00173	0.00173	CcSEcCtD
Sibutramine—Arthralgia—Mesalazine—Crohn's disease	0.00173	0.00173	CcSEcCtD
Sibutramine—Chest pain—Mesalazine—Crohn's disease	0.00173	0.00173	CcSEcCtD
Sibutramine—Anxiety—Mesalazine—Crohn's disease	0.00173	0.00173	CcSEcCtD
Sibutramine—Face oedema—Prednisone—Crohn's disease	0.00173	0.00173	CcSEcCtD
Sibutramine—Discomfort—Mesalazine—Crohn's disease	0.00171	0.00171	CcSEcCtD
Sibutramine—Hypotension—Azathioprine—Crohn's disease	0.0017	0.0017	CcSEcCtD
Sibutramine—Cardiac arrest—Prednisone—Crohn's disease	0.0017	0.0017	CcSEcCtD
Sibutramine—Dry mouth—Mesalazine—Crohn's disease	0.00169	0.00169	CcSEcCtD
Sibutramine—Mood swings—Prednisone—Crohn's disease	0.00169	0.00169	CcSEcCtD
Sibutramine—Confusional state—Mesalazine—Crohn's disease	0.00167	0.00167	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00166	0.00166	CcSEcCtD
Sibutramine—Anaphylactic shock—Mesalazine—Crohn's disease	0.00166	0.00166	CcSEcCtD
Sibutramine—Oedema—Mesalazine—Crohn's disease	0.00166	0.00166	CcSEcCtD
Sibutramine—Infection—Mesalazine—Crohn's disease	0.00165	0.00165	CcSEcCtD
Sibutramine—Dry skin—Prednisone—Crohn's disease	0.00164	0.00164	CcSEcCtD
Sibutramine—Shock—Mesalazine—Crohn's disease	0.00163	0.00163	CcSEcCtD
Sibutramine—Hypokalaemia—Prednisone—Crohn's disease	0.00163	0.00163	CcSEcCtD
Sibutramine—Thrombocytopenia—Mesalazine—Crohn's disease	0.00163	0.00163	CcSEcCtD
Sibutramine—Tachycardia—Mesalazine—Crohn's disease	0.00162	0.00162	CcSEcCtD
Sibutramine—Skin disorder—Mesalazine—Crohn's disease	0.00161	0.00161	CcSEcCtD
Sibutramine—Hyperhidrosis—Mesalazine—Crohn's disease	0.0016	0.0016	CcSEcCtD
Sibutramine—Anorexia—Mesalazine—Crohn's disease	0.00158	0.00158	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00158	0.00158	CcSEcCtD
Sibutramine—Muscular weakness—Prednisone—Crohn's disease	0.00158	0.00158	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00157	0.00157	CcSEcCtD
Sibutramine—Abdominal distension—Prednisone—Crohn's disease	0.00155	0.00155	CcSEcCtD
Sibutramine—Hypotension—Mesalazine—Crohn's disease	0.00155	0.00155	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00151	0.00151	CcSEcCtD
Sibutramine—Feeling abnormal—Azathioprine—Crohn's disease	0.0015	0.0015	CcSEcCtD
Sibutramine—Insomnia—Mesalazine—Crohn's disease	0.0015	0.0015	CcSEcCtD
Sibutramine—Paraesthesia—Mesalazine—Crohn's disease	0.00149	0.00149	CcSEcCtD
Sibutramine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00149	0.00149	CcSEcCtD
Sibutramine—Dyspnoea—Mesalazine—Crohn's disease	0.00148	0.00148	CcSEcCtD
Sibutramine—Somnolence—Mesalazine—Crohn's disease	0.00148	0.00148	CcSEcCtD
Sibutramine—Dyspepsia—Mesalazine—Crohn's disease	0.00146	0.00146	CcSEcCtD
Sibutramine—Decreased appetite—Mesalazine—Crohn's disease	0.00144	0.00144	CcSEcCtD
Sibutramine—Abdominal pain—Azathioprine—Crohn's disease	0.00144	0.00144	CcSEcCtD
Sibutramine—Body temperature increased—Azathioprine—Crohn's disease	0.00144	0.00144	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00143	0.00143	CcSEcCtD
Sibutramine—Erectile dysfunction—Prednisone—Crohn's disease	0.00142	0.00142	CcSEcCtD
Sibutramine—Pain—Mesalazine—Crohn's disease	0.00142	0.00142	CcSEcCtD
Sibutramine—Constipation—Mesalazine—Crohn's disease	0.00142	0.00142	CcSEcCtD
Sibutramine—Weight increased—Prednisone—Crohn's disease	0.00141	0.00141	CcSEcCtD
Sibutramine—Hyperglycaemia—Prednisone—Crohn's disease	0.00139	0.00139	CcSEcCtD
Sibutramine—Depression—Prednisone—Crohn's disease	0.00137	0.00137	CcSEcCtD
Sibutramine—Feeling abnormal—Mesalazine—Crohn's disease	0.00137	0.00137	CcSEcCtD
Sibutramine—Acute coronary syndrome—Prednisone—Crohn's disease	0.00136	0.00136	CcSEcCtD
Sibutramine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00136	0.00136	CcSEcCtD
Sibutramine—Myocardial infarction—Prednisone—Crohn's disease	0.00135	0.00135	CcSEcCtD
Sibutramine—Neuropathy peripheral—Prednisone—Crohn's disease	0.00135	0.00135	CcSEcCtD
Sibutramine—Hypersensitivity—Azathioprine—Crohn's disease	0.00134	0.00134	CcSEcCtD
Sibutramine—Urticaria—Mesalazine—Crohn's disease	0.00132	0.00132	CcSEcCtD
Sibutramine—Abdominal pain—Mesalazine—Crohn's disease	0.00131	0.00131	CcSEcCtD
Sibutramine—Body temperature increased—Mesalazine—Crohn's disease	0.00131	0.00131	CcSEcCtD
Sibutramine—Bradycardia—Prednisone—Crohn's disease	0.00126	0.00126	CcSEcCtD
Sibutramine—Diarrhoea—Azathioprine—Crohn's disease	0.00125	0.00125	CcSEcCtD
Sibutramine—Haemoglobin—Prednisone—Crohn's disease	0.00124	0.00124	CcSEcCtD
Sibutramine—Haemorrhage—Prednisone—Crohn's disease	0.00124	0.00124	CcSEcCtD
Sibutramine—Hypersensitivity—Mesalazine—Crohn's disease	0.00122	0.00122	CcSEcCtD
Sibutramine—Dizziness—Azathioprine—Crohn's disease	0.00121	0.00121	CcSEcCtD
Sibutramine—Asthenia—Mesalazine—Crohn's disease	0.00119	0.00119	CcSEcCtD
Sibutramine—Pruritus—Mesalazine—Crohn's disease	0.00117	0.00117	CcSEcCtD
Sibutramine—Vomiting—Azathioprine—Crohn's disease	0.00116	0.00116	CcSEcCtD
Sibutramine—Eye disorder—Prednisone—Crohn's disease	0.00116	0.00116	CcSEcCtD
Sibutramine—Rash—Azathioprine—Crohn's disease	0.00115	0.00115	CcSEcCtD
Sibutramine—Dermatitis—Azathioprine—Crohn's disease	0.00115	0.00115	CcSEcCtD
Sibutramine—Headache—Azathioprine—Crohn's disease	0.00114	0.00114	CcSEcCtD
Sibutramine—Diarrhoea—Mesalazine—Crohn's disease	0.00114	0.00114	CcSEcCtD
Sibutramine—Angiopathy—Prednisone—Crohn's disease	0.00112	0.00112	CcSEcCtD
Sibutramine—Immune system disorder—Prednisone—Crohn's disease	0.00112	0.00112	CcSEcCtD
Sibutramine—Arrhythmia—Prednisone—Crohn's disease	0.0011	0.0011	CcSEcCtD
Sibutramine—Dizziness—Mesalazine—Crohn's disease	0.0011	0.0011	CcSEcCtD
Sibutramine—Alopecia—Prednisone—Crohn's disease	0.00109	0.00109	CcSEcCtD
Sibutramine—Nausea—Azathioprine—Crohn's disease	0.00108	0.00108	CcSEcCtD
Sibutramine—Malnutrition—Prednisone—Crohn's disease	0.00108	0.00108	CcSEcCtD
Sibutramine—Vomiting—Mesalazine—Crohn's disease	0.00106	0.00106	CcSEcCtD
Sibutramine—Rash—Mesalazine—Crohn's disease	0.00105	0.00105	CcSEcCtD
Sibutramine—Dermatitis—Mesalazine—Crohn's disease	0.00105	0.00105	CcSEcCtD
Sibutramine—Headache—Mesalazine—Crohn's disease	0.00104	0.00104	CcSEcCtD
Sibutramine—Vision blurred—Prednisone—Crohn's disease	0.00101	0.00101	CcSEcCtD
Sibutramine—Ill-defined disorder—Prednisone—Crohn's disease	0.000999	0.000999	CcSEcCtD
Sibutramine—Anaemia—Prednisone—Crohn's disease	0.000995	0.000995	CcSEcCtD
Sibutramine—Agitation—Prednisone—Crohn's disease	0.000989	0.000989	CcSEcCtD
Sibutramine—Nausea—Mesalazine—Crohn's disease	0.000986	0.000986	CcSEcCtD
Sibutramine—Angioedema—Prednisone—Crohn's disease	0.000983	0.000983	CcSEcCtD
Sibutramine—Malaise—Prednisone—Crohn's disease	0.000971	0.000971	CcSEcCtD
Sibutramine—Vertigo—Prednisone—Crohn's disease	0.000967	0.000967	CcSEcCtD
Sibutramine—Syncope—Prednisone—Crohn's disease	0.000965	0.000965	CcSEcCtD
Sibutramine—Loss of consciousness—Prednisone—Crohn's disease	0.000946	0.000946	CcSEcCtD
Sibutramine—Convulsion—Prednisone—Crohn's disease	0.000932	0.000932	CcSEcCtD
Sibutramine—Hypertension—Prednisone—Crohn's disease	0.000929	0.000929	CcSEcCtD
Sibutramine—Arthralgia—Prednisone—Crohn's disease	0.000916	0.000916	CcSEcCtD
Sibutramine—Myalgia—Prednisone—Crohn's disease	0.000916	0.000916	CcSEcCtD
Sibutramine—Anxiety—Prednisone—Crohn's disease	0.000913	0.000913	CcSEcCtD
Sibutramine—Discomfort—Prednisone—Crohn's disease	0.000905	0.000905	CcSEcCtD
Sibutramine—Anaphylactic shock—Prednisone—Crohn's disease	0.000878	0.000878	CcSEcCtD
Sibutramine—Oedema—Prednisone—Crohn's disease	0.000878	0.000878	CcSEcCtD
Sibutramine—Infection—Prednisone—Crohn's disease	0.000873	0.000873	CcSEcCtD
Sibutramine—Shock—Prednisone—Crohn's disease	0.000864	0.000864	CcSEcCtD
Sibutramine—Tachycardia—Prednisone—Crohn's disease	0.000857	0.000857	CcSEcCtD
Sibutramine—Skin disorder—Prednisone—Crohn's disease	0.000853	0.000853	CcSEcCtD
Sibutramine—Hyperhidrosis—Prednisone—Crohn's disease	0.000849	0.000849	CcSEcCtD
Sibutramine—Anorexia—Prednisone—Crohn's disease	0.000837	0.000837	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.0008	0.0008	CcSEcCtD
Sibutramine—Insomnia—Prednisone—Crohn's disease	0.000794	0.000794	CcSEcCtD
Sibutramine—Paraesthesia—Prednisone—Crohn's disease	0.000789	0.000789	CcSEcCtD
Sibutramine—Dyspepsia—Prednisone—Crohn's disease	0.000773	0.000773	CcSEcCtD
Sibutramine—Decreased appetite—Prednisone—Crohn's disease	0.000764	0.000764	CcSEcCtD
Sibutramine—Constipation—Prednisone—Crohn's disease	0.000751	0.000751	CcSEcCtD
Sibutramine—Feeling abnormal—Prednisone—Crohn's disease	0.000724	0.000724	CcSEcCtD
Sibutramine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000718	0.000718	CcSEcCtD
Sibutramine—Urticaria—Prednisone—Crohn's disease	0.000698	0.000698	CcSEcCtD
Sibutramine—Body temperature increased—Prednisone—Crohn's disease	0.000694	0.000694	CcSEcCtD
Sibutramine—Abdominal pain—Prednisone—Crohn's disease	0.000694	0.000694	CcSEcCtD
Sibutramine—Hypersensitivity—Prednisone—Crohn's disease	0.000647	0.000647	CcSEcCtD
Sibutramine—Asthenia—Prednisone—Crohn's disease	0.00063	0.00063	CcSEcCtD
Sibutramine—Pruritus—Prednisone—Crohn's disease	0.000621	0.000621	CcSEcCtD
Sibutramine—Diarrhoea—Prednisone—Crohn's disease	0.000601	0.000601	CcSEcCtD
Sibutramine—Dizziness—Prednisone—Crohn's disease	0.000581	0.000581	CcSEcCtD
Sibutramine—Vomiting—Prednisone—Crohn's disease	0.000558	0.000558	CcSEcCtD
Sibutramine—Rash—Prednisone—Crohn's disease	0.000554	0.000554	CcSEcCtD
Sibutramine—Dermatitis—Prednisone—Crohn's disease	0.000553	0.000553	CcSEcCtD
Sibutramine—Headache—Prednisone—Crohn's disease	0.00055	0.00055	CcSEcCtD
Sibutramine—Nausea—Prednisone—Crohn's disease	0.000522	0.000522	CcSEcCtD
